Discover
EYPT
EyePoint Pharmaceuticals, Inc.
12.69
4 x 12.68
1 x 12.70
bid
ask
-
0.38
2.89%
01:40 PM
timesize
| Ytd | -30.53% | |
| 1y | 23.47% |
12.37
day range
12.87
9.65
52 week range
19.11
| Open | 12.82 | Prev Close | 13.07 | Low | 12.37 | High | 12.87 | Mkt Cap | 1.06B |
| Vol | 972.18K | Avg Vol | 1.39M | EPS | -3.74 | P/E | -3.39 | Forward P/E | -4.54 |
| Beta | 1.76 | Short Ratio | 10.40 | Inst. Own | 110.72% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 13.09 | 200-d Avg | 14.11 | 1yr Est | 40.93 |
| Income Statement | |||
| Total Revenue | 507.00K | ||
| Revenues (USD) | 507.00K | ||
| Gross Profit | 507.00K | ||
| Operating Expenses | 97.89M | ||
| Research and Development Expense | 83.61M | ||
| Selling, General and Administrative Expense | 14.27M | ||
| Operating Income | -97.38M | ||
| Net Income | -94.47M | ||
| Net Income Common Stock | -94.47M | ||
| Net Income Common Stock (USD) | -94.47M | ||
| Consolidated Income | -94.47M | ||
| Earnings per Basic Share | -1.09 | ||
| Earnings per Basic Share (USD) | -1.09 | ||
| Earnings per Diluted Share | -1.09 | ||
| Earning Before Interest & Taxes (EBIT) | -94.47M | ||
| Earning Before Interest & Taxes (USD) | -94.47M | ||
| Weighted Average Shares | 86.54M | ||
| Weighted Average Shares Diluted | 86.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 110.61M | ||
| Cash and Equivalents (USD) | 110.61M | ||
| Investments | 70.01M | ||
| Investments Current | 70.01M | ||
| Trade and Non-Trade Receivables | 86.00K | ||
| Current Assets | 188.82M | ||
| Property, Plant & Equipment Net | 29.86M | ||
| Total Assets | 228.19M | ||
| Total Debt | 19.81M | ||
| Current Liabilities | 41.94M | ||
| Debt Non-Current | 19.81M | ||
| Total Liabilities | 61.78M | ||
| Accumulated Retained Earnings (Deficit) | -1.28B | ||
| Accumulated Other Comprehensive Income | 793.00K | ||
| Shareholders Equity | 166.41M | ||
| Shareholders Equity (USD) | 166.41M | ||
| Assets Non-Current | 39.37M | ||
| Total Debt (USD) | 19.81M | ||
| Inventory | 1.88M | ||
| Liabilities Non-Current | 19.84M | ||
| Trade and Non-Trade Payables | 17.27M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 690.00K | ||
| Net Cash Flow from Financing | 19.99M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 32.75M | ||
| Capital Expenditure | -1.20M | ||
| Issuance (Purchase) of Equity Shares | 20.18M | ||
| Issuance (Repayment) of Debt Securities | -28.00K | ||
| Net Cash Flow from Investing | 75.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 76.30M | ||
| Net Cash Flow from Operations | -62.35M | ||
| Share Based Compensation | 10.40M | ||